{"gao_id": "GAO-18-480", "published": "2018-06-21T12:00:00Z", "released": "2018-06-28T08:00:00Z", "summary": "To have their drugs covered under Medicaid, the \"340B\" program requires drug manufacturers to sell outpatient drugs to covered entities\u2014certain hospitals and clinics\u2014at a discount. These entities are increasingly contracting with pharmacies to dispense 340B drugs. Doing so can make it harder to ensure compliance with 340B rules. For example, contract pharmacies may also fill prescriptions for the general public, increasing the risk of dispensing...", "title": "Drug Discount Program: Federal Oversight of Compliance at 340B Contract Pharmacies Needs Improvement", "topics": ["Discount rates", "Drug prices", "Outpatient care", "Prescription drugs", "Medicaid", "Patient care", "Health Care", "Medicaid program", "Health care centers", "Hospitals", "Drugs", "Pharmacy", "Internal controls", "Health care", "Medically uninsured"], "type": "reports-testimonies", "url": "https://www.gao.gov/products/gao-18-480", "versions": [{"title": "Highlights Page (1 page)", "url": "https://www.gao.gov/assets/gao-18-480-highlights.pdf"}, {"title": "Full Report (68 pages)", "url": "https://www.gao.gov/assets/gao-18-480.pdf"}, {"title": "Accessible PDF (83 pages)", "url": "https://www.gao.gov/assets/700/693080.pdf"}]}